Entrada Therapeutics, Inc. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Advisory Agreements (1 contract)
- Collaboration Agreements (4)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Strategic Collaboration and License Agreement, dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on March 13, 2024)
- Amendment to Strategic Collaboration and License Agreement, dated October 26, 2023, by and between Entrada Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated (Filed With SEC on November 1, 2023)
- Sales Agreement, by and between Entrada Therapeutics, Inc. and Cowen and Company, LLC, dated as of September 29, 2023 (Filed With SEC on September 29, 2023)
- Strategic Collaboration and License Agreement, dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on May 10, 2023)
- Strategic Collaboration and License Agreement, dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on March 6, 2023)
- Amended and Restated Strategic Advisory Agreement, by and between the Registrant and Peter S. Kim, to be in effect as of the closing of this offering (Filed With SEC on October 25, 2021)
- Form of Indemnification Agreement between the Registrant and each of its executive officers (Filed With SEC on October 25, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors (Filed With SEC on October 25, 2021)
